Statement from Professor Ewan McKendrick, Registrar of Oxford University, regarding BBC’s File on 4 programme (6 June 2017) examining the role of animal experiments in the development of a new human vaccine for tuberculosis.
Jenner scientist Dr Rachel Tanner has been awarded an NC3Rs Skills and Knowledge Transfer Grant for the transfer of a novel non-human primate in vitro mycobacterial growth inhibition assay. The assay will be transferred to Public Health England and the Biomedical Primate Research Centre, with the aim of refining and reducing use of non-human primate TB infection models in the early evaluation of TB vaccine candidates.
Development of an objective gene expression panel as an alternative to self-reported symptom scores in human influenza challenge trials. J Transl Med, 15 (1), pp. 134. Article
The next chapter for group B meningococcal vaccines. Crit Rev Microbiol, pp. 1-17. Article
Clinical trials are an essential part of vaccine development, and our volunteers play a critical role in our studies.
If you would like to find out more about paid clinical trials, and what is involved in participating, please go to our Recruiting Trials page to see which trials are currently recruiting.
Dr Richard Webby: Swine influenza; a potpourri of pork and pathogen, 26/Jul/2017 16:00
Prof Vincenzo Cerundolo: Amino acid degrading enzymes and their role in tumour immune escape mechanisms, 15/Sep/2017 14:00